Page 77 - JCBP-2-3
P. 77

Journal of Clinical and
            Basic Psychosomatics                                                          HD-tDCS on pain in SSD-P



            States) with a 4 × 1 adaptor. An adult HD cap was used   3. Results
            to hold the electrodes in place. The proprietary HD-tDCS
            electrodes (1.2  cm external diameter) fitted in the HD   3.1. Sociodemographic and clinical profile
            electrode holders supplied with the device were used for   Table 1 presents the sociodemographic and clinical profile
            the interventions.                                 of the participants in the study, comparing those entering

              In the active phase, a 2 mA current was delivered after   the active arm first to those entering the sham arm first.
            a ramp-up time of 30 seconds. In the sham phase, there   The two groups were largely comparable.
            was a brief period of stimulation in which the patient   Overall, a majority of the participants were female
            would have a sensation of current flowing, but no actual   (~70%) and had moderate-to-severe somatic symptoms.
            current flow would occur. The intervention consisted   Comorbid physical conditions were observed in one-
            of one session of repeated active or sham HD-tDCS   fourth of the patients, with the most common being
            administration, followed by a washout period of 1 week.   hypertension, followed by diabetes and hypothyroidism.
            After this period, the patients entered the sham or active   Males and females across the two groups were
            phase  of  the  study,  respectively.  Thus,  each  patient   statistically comparable on baseline sociodemographic
            received both active and sham stimulation by the end of
            2 weeks.
                                                               Table 1. Sociodemographic and baseline clinical profile
            2.6. Randomization                                 of Group A (active followed by sham) and Group B (sham
                                                               followed by active)
            A consecutive sampling technique and simple
            randomization were utilized. Eligible patients were   Variable          Group A   Group B   P‑value
            randomized in a 1:1 allocation ratio by computer-                       (n=16)   (n=14)
            assigned random allocation to one of two treatment   Age (years)        40.44 (8.93) 39.29 (11.18) 0.75
            arms: active or sham HD-tDCS and concealed in      Education (years)    11.00 (5.81) 10.64 (7.26)  0.88
            sealed envelopes. The random allocation sequence was   Gender                              0.41
            generated by one of the authors, while another author   Male            3 (18.7%)  5 (35.7%)
            was responsible for enrolling participants and assigning   Female       13 (81.3%)  9 (64.3%)
            them to the treatment sequence. Patients were blinded to   Duration of illness (years)  8.44 (5.27)  8.71 (7.28)  0.90
            the treatment sequence. Due to the reduction in sample
            size, 16 patients were allocated to the active followed by   DSM-5 severity of             0.56
                                                               somatic symptoms
            the sham treatment arm (Group A), and 14 patients were
            allocated to the sham followed by the active treatment   Mild to moderate  11 (68.8%)  9 (64.3%)
            arm (Group B).                                      Severe              5 (31.2%)  5 (35.7%)
                                                               Comorbid physical diagnosis  4 (25.0%)  4 (28.6%)  0.90
            2.7. Analysis                                      Comorbid substance    0 (0%)  3 (21.5%)  0.05

            Descriptive analysis in terms of frequencies, means,   use (alcohol)
            and standard deviations, as well as Chi-square tests   NRS              7.50 (1.97)  8.42 (1.65)  0.44
            for ordinal data and  t-tests for normally distributed   BPI-H (average pain)  7.00 (1.75)  7.71 (2.02)  0.87
            data, was employed. Repeated measures analysis of   BPI-H (interference)  6.10 (2.22)  7.09 (1.63)  0.34
            variance (ANOVA) was employed to test the hypothesis   GAD-7            12.12 (6.30) 12.71 (4.97)  0.64
            regarding  the  effect  of  HD-tDCS  on  the  pain  scores,
            with treatment order (active-sham versus sham-active),   PHQ- 9         13.12 (6.37) 14.28 (4.76)  0.23
            treatment condition (active versus sham), and time   SSS- 8             17.56 (8.79) 17.14 (8.06)  0.44
            (baseline, immediately after stimulation, and at follow-  PDI-7         38.31    41.35 (18.78) 0.23
            ups) as the independent variables. Analysis of covariance               (11.92)
            (ANCOVA) was applied to test the interaction of    MMSE                 29.62 (0.81) 29.85 (0.53)  0.63
            order and treatment group. ANCOVA test was chosen   CGI-S               4.06 (0.77)  4.07 (0.83)  0.45
            as it has been considered to increase the statistical   Notes: Results are expressed in frequency (%) or mean (SD); Significant
            power of crossover studies, as in this case. ANCOVA   level was set at P<0.05.
            improves precision and avoids bias in the widest set of   Abbreviations: BPI-H: Brief Pain Inventory-Hindi version: CGI-S:
            circumstances.  In addition, our scores were measured   Clinical Global Impression-Severity: GAD-7: Generalized Anxiety
                        27
                                                               Disorder 7 Scale: MMSE: Mini-Mental State Assessment; NRS:
            across three-time points. Statistical analysis was   Numerical Rating Scale; PDI-7: Pain Disability Index 7; PHQ-9: Patient
            conducted using SPSS software version 21.          Health Questionnaire 9; SSS-8: Somatic Symptom Scale-8.

            Volume 2 Issue 3 (2024)                         4                               doi: 10.36922/jcbp.2002
   72   73   74   75   76   77   78   79   80   81   82